Stock Screener: Medical , Medical-Biomed-Genetics

The medical or healthcare sector comprises of those stocks which are involved in the production of medical goods.
Medical-Biomed-Genetics belongs to the sector Medical. This industry has a Market Cap of 712.08B. The top rated companies for Medical-Biomed-Genetics industry are: Amgen (AMGN) , Celgene (CELG) , Gilead Sciences (GILD).

Select Sector Select Industry
Click on the column to sort the table.
Company Stock Rating Market Cap PE Ratio 1W 52W
Amgen (AMGN)
4.5/5 114.3B 14.72 1.3% -1.1%
Anika Therapeutics (ANIK)
4.3/5 680.71M 22.31 -1.32% -2.51%
Biogen Inc (BIIB)
4.1/5 54.04B 15.72 0.3% -11.31%
Cambrex (CBM)
4.1/5 1.74B 20.34 2.39% 9.9%
Gilead Sciences (GILD)
4.1/5 84.36B 6.82 0.22% -24.84%
Alexion Pharma (ALXN)
4.0/5 22.12B 46.75 -15.35% -35.05%
Celgene (CELG)
4.0/5 91.15B 44.07 0.92% 9.72%
Innoviva (INVA)
4.0/5 1.32B 19.32 0.75% 9.15%
PDL BioPharma (PDLI)
3.9/5 376.7M 26.56 1.7% -28.44%
Emergent Biosolutions (EBS)
3.9/5 1.24B 29.73 8.77% -26.52%
Regeneron Pharma (REGN)
3.8/5 48.44B 54.77 -1.26% 14.88%
China Biologic Products (CBPO)
3.8/5 3.1B 29.45 1.64% -2.65%
Enzo Biochem (ENZ)
3.7/5 418.94M 13.55 1.57% 46.93%
Illumina (ILMN)
3.6/5 25.37B 34.83 0.57% 22.29%
Myriad Genetics (MYGN)
3.6/5 1.38B 45.13 -3.97% -40.42%
BioTechne Corporation (TECH)
3.5/5 4.15B 59.89 0.96% 1.63%
ANI Pharma (ANIP)
3.5/5 551.62M 139.30 -2.21% -12.07%
Repligen (RGEN)
3.5/5 1.32B 103.32 0.26% 61.96%
Heska (HSKA)
3.4/5 697.16M 52.09 1.1% 165.32%
MiMedx (MDXG)
3.4/5 1.53B 95.71 -6.49% 68.55%
VIVUS (VVUS)
3.3/5 118.25M 3.42 4.63% -8.13%
Integra LifeSciences (IART)
3.3/5 3.75B 58.39 2.23% 32.76%
Qiagen (QGEN)
3.2/5 7.42B 91.39 0.89% 47.09%
AMAG Pharma (AMAG)
3.2/5 637.83M - 1.62% -10.31%
Osiris Therapeutics (OSIR) 3.1/5 198.18M 78.00 -5.57% -1.41%
Ligand Pharma (LGND)
3.0/5 2.38B - -2.86% -10.28%
Horizon Pharma (HZNP)
2.8/5 1.62B - -1.26% -38.55%
Vertex Pharma (VRTX)
2.8/5 29.54B 173.80 0.82% 32.68%
Momenta Pharma (MNTA)
2.8/5 1.11B - -0.34% 32.41%
Incyte (INCY)
2.7/5 28.34B - -0.04% 58.97%
Exelixis (EXEL)
2.6/5 5.72B - 0.26% 205.21%
Cytokinetics (CYTK)
2.6/5 683.92M - -1.05% 73.86%
Retrophin (RTRX)
2.5/5 648.18M - -2.31% -5.5%
Genomic Health (GHDX)
2.5/5 1.01B - 3.45% 15.08%
Acorda Therapeutics (ACOR)
2.4/5 678.9M - -6.86% -47.78%
Vanda Pharmaceuticals (VNDA)
2.4/5 625.96M - -1.06% 32.42%
Sinovac Biotech (SVA)
2.4/5 287.67M - 13.12% -13.63%
BioMarin Pharma (BMRN)
2.4/5 15.24B - -2.75% -1.22%
NeoGenomics (NEO)
2.3/5 598.24M - 1.93% -17.91%
Galapagos (GLPG)
2.3/5 4.27B 1655.80 -3.52% 41.47%
Alkermes (ALKS)
2.3/5 8.88B - -1.06% 25.08%
Seattle Genetics (SGEN)
2.3/5 9.42B - -1.41% 62.95%
Organovo (ONVO)
2.3/5 297.57M - 4.63% 4.63%
EXACT Sciences (EXAS)
2.3/5 3.69B - 4.78% 412.62%
Kamada (KMDA)
2.2/5 258.78M - 0.7% 92.2%
MyoKardia (MYOK)
2.2/5 405.78M - -5.22% 1.03%
Nymox Pharmaceutical (NYMX) 2.2/5 191.71M - 3.76% 63.56%
Arna Pharma (ARNA)
2.2/5 431.71M - -2.24% -25.14%
Cellectis (CLLS)
2.1/5 857.56M - -0.99% -23.09%
Array BioPharma (ARRY)
2.1/5 1.41B - -3.55% 126.67%
Amarin (AMRN)
2.1/5 830.49M - 0.34% 60.22%
Keryx Biopharma (KERX)
2.1/5 696.36M - 2.22% 10.24%
Compugen (CGEN)
2.1/5 260.77M - 0 -26.06
Halozyme Therapeutics (HALO)
2.1/5 1.76B - -2.97% 24.1%
Intellia Therapeutics (NTLA)
2.1/5 489.99M - -6.29% -55.02%
Editas (EDIT)
2.1/5 674.39M - -10.49% -55.65%
Geron (GERN)
2.0/5 479.12M - -9.48% -2.81%
Spark Therapeutics (ONCE)
2.0/5 1.73B - -2.11% -5.85%
Regenxbio (RGNX)
2.0/5 574.82M - -0.55% 43.54%
Curis (CRIS)
2.0/5 244.41M - -0.58% 1.18%
Lexicon Pharma (LXRX)
2.0/5 1.53B - -0.69% 5.34%
Idera Pharma (IDRA)
1.9/5 249.08M - -6.4% 8.05%
Alnylam Pharma (ALNY)
1.9/5 6.36B - -11% -2.62%
Blueprint Medicines (BPMC)
1.9/5 1.5B - -8.7% 95.97%
Agenus (AGEN)
1.9/5 346.92M - 1.47% -14.81%
Evogene (EVGN) 1.8/5 131.16M - 0.47% -23%
CytomX Therapeutics (CTMX)
1.8/5 533.24M - -3.11% 34.75%
Acceleron Pharma (XLRN)
1.8/5 1.02B - -0.63% -25.49%
Arbutus Biopharma (ABUS) 1.8/5 192.59M - -8.22% -18.29%
Merrimack Pharma (MACK)
1.8/5 450.26M - -6.78% -47.7%
Juno Therapeutics (JUNO)
1.8/5 2.71B - -3.2% -44.58%
Inovio Pharma (INO)
1.8/5 596.27M - 11.14% -25.73%
Kite Pharma (KITE)
1.8/5 4.24B - 2.15% 52.98%
Intercept Pharma (ICPT)
1.8/5 2.88B - -1.38% -20.89%
Acadia Pharma (ACAD)
1.8/5 3.21B - -7.1% -26.93%
Five Prime Therapeutics (FPRX)
1.8/5 857.53M - -0.17% -35.52%
Abeona Therapeutics (ABEO)
1.8/5 229.45M - -6.72% 70.25%
Aduro BioTech (ADRO)
1.8/5 713.12M - 0.5% -14.18%
Peregrine Pharma (PPHM)
1.7/5 168.38M - 1.07% 36.71%
Celldex Therapeutics (CLDX)
1.7/5 387.83M - 0 -29.33
Mesoblast (MESO)
1.7/5 676.16M - -12.46% 11.87%
Uniquire (QURE)
1.7/5 138.27M - -0.89% -53.38%
Stemline Therapeutics (STML)
1.7/5 209.71M - 4.97% 8.19%
Adverum (ADVM) 1.7/5 113.6M - -3.57% -40%
Dynavax Technologies (DVAX)
1.6/5 270.8M - 3.64% -64.04%
ZIOPHARM Oncology (ZIOP)
1.6/5 933.53M - -10.14% -14.88%
bluebird bio (BLUE)
1.6/5 3.27B - -0.32% 78.26%
NewLink Genetics (NLNK)
1.6/5 445.4M - -5.1% 28.38%
Adaptimmune Therapeutics (ADAP)
1.6/5 375.22M - -1.66% -45.99%
The Medicines Company (MDCO)
1.6/5 2.84B - -4.68% 3.9%
Sangamo BioSciences (SGMO)
1.6/5 561.13M - -2.68% 8.7%
Immunomedics (IMMU)
1.6/5 818.74M - 2.25% 67.1%
Achillion Pharma (ACHN)
1.5/5 567.4M - 1.45% -53.74%
Merus (MRUS)
1.5/5 373.67M - -1.9% 150.39%
Prothena (PRTA)
1.5/5 2.09B - -7.52% 11.43%
Coherus Biosciences (CHRS)
1.5/5 1.04B - -4.03% 12.75%
NantKwest (NK)
1.5/5 343.41M - -2.45% -48.99%
Ascendis Pharma (ASND)
1.5/5 813.54M - -6.99% 73.2%
Cara Therapeutics (CARA)
1.4/5 543.2M - -5% 162.32%
Novavax (NVAX)
1.4/5 282.83M - -2.94% -83.11%
Revance (RVNC)
1.4/5 643.31M - 7.86% 10.69%
Amicus Therapeutics (FOLD)
1.4/5 1.18B - -5.71% 12.32%
Reata Pharma (RETA)
1.4/5 394.14M - 8.39% 89.08%
Wave Life Sciences (WVE)
1.4/5 555.74M - -3.59% 29.75%
Vtv Therapeutics (VTVT)
1.4/5 162.42M - 1.01% -12.01%
MediciNova (MNOV)
1.4/5 208.97M - 5.31% -11.72%
Selecta Biosciences (SELB)
1.4/5 251.22M - 0.86% 0.36%
MIRAGEN THERAP (MGEN)
1.3/5 226.65M - -7.77% 15.47%
Epizyme (EPZM)
1.3/5 942.48M - -6.59% 43.65%
Beigene (BGNE)
1.3/5 1.18B - -0.35% 37.27%
Syndax Pharma (SNDX)
1.3/5 284.17M - -9.51% -4.82%
Fate Therapeutics (FATE)
1.3/5 142.84M - -13.23% 110.26%
OncoMed Pharma (OMED)
1.3/5 132.43M - 0.55% -74.83%
Advaxis (ADXS)
1.2/5 350.57M - -1.63% -6.75%
Alder BioPharma (ALDR)
1.2/5 859.5M - -7.45% -44.39%
Insmed (INSM)
1.2/5 1.06B - -7.48% 35.84%
Intra-Cellular Therapies (ITCI)
1.2/5 455.48M - -4.15% -72.78%
Paratek Pharma (PRTK)
1.2/5 570.33M - -5.85% 31.03%
Trevena (TRVN)
1.1/5 166.74M - -7.05% -60.76%
Sarepta Therapeutics (SRPT)
1.1/5 1.7B - -8.17% 41.62%
IR Biosciences (IRBS) - 0M - 0 -100
Avax Technologies (AVXT) - 1.72M - 0 -75
Basilea Pharma (BPMUF) - 955.6M - 0 4.93
Palatin Technologies (PTN) - 58.06M - -7.04% -30.58%
GeoVax Labs (GOVX) - 2M - -12.5% -52.7%
Savient Pharma (SVNTQ) - 0.59M - N/A N/A
Marina Biotech (MRNA) - 30.6M 15.70 5.02% 19.85%
Nanobac Pharma (NNBP) - 0.17M - 0 0
Introgen Therapeutics (INGNQ) - 0M - N/A N/A
US Stem Cell (USRM) - 34.88M 1.30 -15.45% 131.11%
Affymax (AFFY) - 1.99M - -7.14% -30.67%
Oncolytics Biotech (ONCYF) - 57.51M - -29.01% 8.24%
Protalix Biotherapeutics (PLX) - 115.11M - 17.31% 15.68%
Rexahn Pharma (RNN) - 100.42M - 2.02% 1242.19%
VIA Pharma (VIAP) - 0.1M - 100% 66.67%
CSL Ltd (CMXHY) - 30.75B - N/A N/A
NeurogesX (NGSX) - 0.17M - N/A N/A
Dendreon (DNDNQ) - 5.4M - N/A N/A
HedgePath Pharma (HPPI) - 129.36M - 4.76% 65%
Myrexis (MYRX) - 2.14M - -20.51% 6.9%
Pfenex (PFNX) - 95M 27.67 -1.19% -36.25%
Interleukin Genetics (ILIU) - 15.15M - -11.11% -54.29%
Insite Vision (INSV) - 45.85M - N/A N/A
Synthetic Biologics (SYN) - 72.16M - 12.2% -71.37%
ARYx Therapeutics (ARYX) - 0.11M - 0 50
Immune Therapeutics (IMUN) - 16.7M - -12.31% -59.57%
Bionovo (BNVIQ) - 0.02M - N/A N/A
Panacos Pharma (PANC) - 0.01M - 0 0
Protein Polymer (PPTIQ) - 0.06M - 0 0
Wowi (WOWU) - 5.98B - 0 168.75
Gliatech (GLIAQ) - 0M - N/A N/A
Cellcyte Genetics (CCYG) - 0.21M - 0 0
Viralytics (VRACY) - 195.44M - -4.69% 26.42%
Cormedix (CRMD) - 25.25M - -9.77% -84.98%
GeneLink (GNLKQ) - 0.32M - -100 0
Nicox (NICXF) - 281.8M - 0 -8.09
Atara Bio (ATRA) - 419.17M - -6.25% -18.71%
ImmunoCellular Therapeutics (IMUC) - 3.95M - 0 -87.66
International Stem Cell Corp (ISCO) - 5.97M 6.29 -19.51% -43.35%
Addex Therapeutics (ADDXF) - 31.62M - 0 -17.54
Theratechnologies (THERF) - 368.44M - 3.9% 134.41%
Biocoral (BCRA) - 1.23M - N/A N/A
BioTime (BTX) - 363.67M 3.28 -1.52% 12.85%
Pathfinder Cell (PFND) - 2M - 0 50
Provectus Biopharma (PVCT) - 15.63M - -8.7% -88.37%
Regenicin (RGIN) - 15.24M - 0 284.62
Genitope (GTOPQ) - 0.06M - 0 0
ZYTO Corp (KAEN) - 1.12M - -8.57% 6.67%
Volitionrx (VNRX) - 92.79M - 0.59% 2.72%
Deltagen (DGEN) - 0M - 0 -100
Helix Biomedix (HXBM) - 7.85M - 0 0.42
Lion Biotech (LBIO) - 383.46M - -7.38% -2.92%
USA Equities Corp (USAQ) - 0.54M - 0 36.36
Nutra Pharma (NPHC) - 1M - -25% -66.67%
Accentia BioPharma (ABPI) - 0.01M - N/A N/A
Arbutus Biopharma (ABUS) - 192.59M - -8.22% -18.29%
Bellus Health (BLUSF) - 16.58M - 34.35% -84.55%
Quick-Med Technologies (QMDT) - 1.93M - 0 372.73
Redpoint Bio (RPBC) - 0.09M - 0 0
Health Discovery (HDVY) - 2.72M - 11.11% -72.22%
Respirerx Pharma (RSPI) - 5.95M - 1.96% -55.47%
iBio (IBIO) - 32.92M - 0 -44.78
Williston Holding (WHCA) - 3.14M - 0 515.38
Vital Therapies (VTL) - 119.24M - -6.56% -65.66%
YBCC INC (YBAO) - 4.75M - 0 20
Synvista Therapeutics (SYNI) - 0.01M 0.00 -100 0
PROTAGENIC THER (PTIX) - 20.51M - 0 -88.24
Biocurex (BOCX) - 0M - N/A N/A
Puma Biotech (PBYI) - 2.89B - 51.62% 113.92%
Response Genetics (RGDXQ) - 0.05M - -100% -100%
Genmab (GNMSF) - 12.97B 108.62 0 17.86
Cel-Sci Corporation (CVM) - 18.4M - -28.1% -82.77%
Unigene Laboratories (UGNEQ) - 0.07M - -100 0
Taxus Cardium Pharma (CRXM) - 2.43M - 33.06% -11.54%
DBV Tech (DBVT) - 1.66B - -2.32% 2.18%
Starpharma (SPHRY) - 182.64M - -2.57% -2.95%
Advanced Life Sciences (ADLS) - 0M - 0 -100
BioForce Nanosciences (BFNH) - 1.14M - 125% 275%
Oragenics (OGEN) - 24.14M - -1.41% -14.04%